PUMA BIOTECHNOLOGY, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 1,190.8% | -30.8% | -12.9% |
| FY2022 | 0.0% | 0.0% | 0.0% |
| FY2023 | 40.4% | 18.1% | 9.4% |
| FY2024 | 32.9% | 26.6% | 14.2% |
| FY2025 | 23.9% | 23.9% | 14.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 1,190.8% | -30.8% | -12.9% |
| FY2022 | 0.0% | 0.0% | 0.0% |
| FY2023 | 40.4% | 18.1% | 9.4% |
| FY2024 | 32.9% | 26.6% | 14.2% |
| FY2025 | 23.9% | 23.9% | 14.4% |